Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.

Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.

Item
http://www.wikidata.org/entity/Q34791678
SB 206553, a putative 5-HT2C inverse agonist, attenuates methamphetamine-seeking in ratsSerotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderCritical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adultsSerotonin 2A receptors differentially contribute to abuse-related effects of cocaine and cocaine-induced nigrostriatal and mesolimbic dopamine overflow in nonhuman primatesThe serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Striatal dopamine release and genetic variation of the serotonin 2C receptor in humansPrior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.Opponency revisited: competition and cooperation between dopamine and serotonin.Presynaptic control of serotonin on striatal dopamine function.Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.Prediction of Efficacy of Vabicaserin, a 5-HT2C Agonist, for the Treatment of Schizophrenia Using a Quantitative Systems Pharmacology Model.Prenatal activation of maternal TLR3 receptors by viral-mimetic poly(I:C) modifies GluN2B expression in embryos and sonic hedgehog in offspring in the absence of kynurenine pathway activation.Pre-hatching fluoxetine-induced neurochemical, neurodevelopmental, and immunological changes in newly hatched cuttlefish.Anatomical relationships between serotonin 5-HT2A and dopamine D2 receptors in living human brain.Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjects.Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.
P2860

Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.

Item
http://www.wikidata.org/entity/Q34791678
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Modulation of striatal dopamin ...... opride PET studies in the rat.
@ast
Modulation of striatal dopamin ...... opride PET studies in the rat.
@en
Modulation of striatal dopamin ...... opride PET studies in the rat.
@nl
type
label
Modulation of striatal dopamin ...... opride PET studies in the rat.
@ast
Modulation of striatal dopamin ...... opride PET studies in the rat.
@en
Modulation of striatal dopamin ...... opride PET studies in the rat.
@nl
prefLabel
Modulation of striatal dopamin ...... opride PET studies in the rat.
@ast
Modulation of striatal dopamin ...... opride PET studies in the rat.
@en
Modulation of striatal dopamin ...... opride PET studies in the rat.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Modulation of striatal dopamin ...... opride PET studies in the rat.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921